Furthermore, we found that the overexpression of miR-204-5p inhibited the osteogenic potential of T2DM-BMSCs, and co-overexpression of IGFBP5 reversed this inhibitory effect (Figures 4C–F). This evidence concerns the gene IGFBP5 and type 2 diabetes mellitus.